In the world of diagnostics, the materials used in tests are not just important—they are critical. Porex explains how they influence everything from the accuracy of results to the speed and reliability of testing.
Menopause has finally emerged from the shadows of taboo and silence. This newfound openness is a welcome change, as it encourages a more comprehensive understanding of women’s health and the challenges that come with menopause.
In today’s rapidly evolving healthcare landscape, the integration and effective use of data stands as a pivotal challenge. Integrated Care Systems and NHS trusts are striving to digitally transform their operations, and to integrate new digital tech.
Commercial director Rory O’Keeffe, from Europlaz Technologies, identifies what to look for and what to be wary of when evaluating a reliable medical device manufacturer.
Commercial director, Rory O’Keeffe, Europlaz, examines the latest innovations that the team believes will be transformative to future clinical pathways.
Chris Whitehouse, political consultant and expert on medtech policy and regulation at Whitehouse Communications, advisor to medtech suppliers, chair of the Urology Trade Association, looks at the prognosis and treatment for the “broken” NHS.
Ahead of DxPx U.S., the industry + investor partnering conference dedicated to diagnostics, digital health, precision medicine, and life sciences tools, five key trends are emerging that are set to define the future of the industry.
Ashlee Gough at Sumitomo (SHI) Demag UK reviews the tipping point when injection moulding machinery loses its value, becomes financially unviable to maintain, and can hit you where it hurts most … on the bottom line.
After a historic general election in the UK, with the Conservatives ending up with the lowest number of seats in the party’s history, and Sir Keir Starmer becoming the nation’s Prime Minister, MTI reached out to contacts in the UK MedTech industry.
The 2024 Spring Budget announced a £4.2 billion boost for the healthcare sector. £3.4 billion of that is set aside for the NHS over three years to help the system work better, through increased investment in technology.
Dr Ameera Patel, CEO of TidalSense, an AI respiratory healthtech pioneer for COPD and asthma solutions, questions whether our healthcare systems have become too reliant on disposable medical devices.
